Methotrexate: Difference between revisions

 
(2 intermediate revisions by 2 users not shown)
Line 3: Line 3:
*Dosage Forms:
*Dosage Forms:
*Routes of Administration: IV/IM, oral  
*Routes of Administration: IV/IM, oral  
*Common Trade Names:  
*Common Trade Names: Trexall, Rheumatrex, Otrexup


==Adult Dosing==
==Adult Dosing==
Line 50: Line 50:


==Mechanism of Action==
==Mechanism of Action==
*Inhibits dihydrofolate reductase--> blocks DNA synthesis and thus, cellular replication/repair
*Inhibits dihydrofolate reductase→ blocks DNA synthesis and thus, cellular replication/repair
==Comments==
==Comments==


==See Also==
==See Also==
[[Methotrexate_toxicity]]


==References==
==References==
<references/>
<references/>
[[Category:Pharmacology]]
[[Category:Pharmacology]]

Latest revision as of 19:44, 8 March 2021

Administration

  • Type: Immunosuppressant/antineoplastic
  • Dosage Forms:
  • Routes of Administration: IV/IM, oral
  • Common Trade Names: Trexall, Rheumatrex, Otrexup

Adult Dosing

Ectopic pregnancy

  • Single-dose regimen: Methotrexate 50 mg/m2

Pediatric Dosing

Special Populations

Renal Dosing

  • Adult:
  • Pediatric:

Hepatic Dosing

  • Adult:
  • Pediatric:

Contraindications

  • Allergy to class/drug
  • Breastfeeding, pregnant, or possibility of impregnating someone
  • Blood dyscrasias
  • Chronic liver disease

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life: 8-15hr
  • Metabolism: Extensive hepatic and intracellular
  • Excretion: Mostly renal. Dialyzable.

Mechanism of Action

  • Inhibits dihydrofolate reductase→ blocks DNA synthesis and thus, cellular replication/repair

Comments

See Also

Methotrexate_toxicity

References